Injectables regulations: Taming the aesthetics Wild West

At present, there is a ‘complete absence’ of regulations for aesthetic non-surgical cosmetic treatments in the UK, but industry bodies are collaborating to push for change

In July, the All Party Parliamentary Group on Beauty, Aesthetics and Wellbeing (BAW APPG) published its final report on regulations over Botox, filler and other aesthetic non-surgical cosmetics treatments in the UK – or the lack thereof.

The report highlighted a complete lack of legal framework of standards and qualifications around such treatments, leaving consumers at risk and undermining the industry’s ability to develop.

Its authors, Carolyn Harris MP and Judith Cummins MP, helmed a year-long inquiry prior to the report’s publication, which was set up in response to an explosion in the popularity and availability of injectable aesthetic treatments.

The ultimate aim of the APPG is to ensure all practitioners gain the appropriate training and can prove their competence to deliver advanced aesthetic treatments – and, to this end, 17 recommendations were made for the UK government in its report.

“Concerningly, regulation varies throughout the UK, and is fragmented, obscure and out of date,” Harris and Cummins tell Cosmetics Business.

. . .

This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.

Or

Subscribe now to premium content on Cosmetics Business

Companies